Skip to main content
. 2020 Oct 29;21(21):8071. doi: 10.3390/ijms21218071
AGE advanced glycation end products
AMPK AMP-activated protein kinase
AOPP advanced oxidation protein products
CAT catalase
FOXO3a forkhead box O3a
FRAP ferric reducing ability of plasma
G-CSF granulocyte colony-stimulating factor
GM-CSF granulocyte-macrophage colony stimulating factor
GPx glutathione peroxidase
GRO KC/CXCL1 growth-regulated oncogene/keratinocyte chemoattractant/chemokine (C-X-C motif) ligand 1
GSH reduced glutathione
HO-1 heme oxygenase-1
IFNγ interferon γ
IL interleukin
IL-1ra interleukin-1 receptor antagonist
JNK c-Jun N-terminal kinases
Km Michaelis–Menten constant
LOOH lipid hydroperoxides
MAA malondialdehyde acetaldehyde
MAPK mitogen activated protein kinase
MCP1/CCL2 monocyte chemoattractant protein 1/chemokine (C-C motif) ligand 2
M-CSF macrophage colony-stimulating factor
MDA malondialdehyde
MIP-1α/CCL3 macrophage inflammatory protein-1α/chemokine (C-C motif) ligand 3
MIP-3α/CCL20 macrophage inflammatory protein-3α/chemokine (C-C motif) ligand 20
NADPH nicotinamide adenine dinucleotide phosphate
NEFA non-esterified fatty acids
NF-κB nuclear factor κB
NO nitric oxide
NOS nitric oxide synthase
Nrf2 nuclear factor-like 2
RAGE receptor for advanced glycation end products
RANTES/CCL5 regulated on activation, normal T-cell expressed and secreted/chemokine (C-C motif) ligand 5
SOD superoxide dismutase
TNFα tumor necrosis factor α
VEGF vascular endothelial growth factor